肝脏疾病中的肠道微生物群:启动,发展和治疗
Jian-Xiu Yu1, Jun Wu1, Xin Chen1
1Medical Laboratory Department, Affiliated Dongtai Hospital of Nantong University, Dongtai, China.
Frontiers in medicine
|June 19, 2025
概括
肠道微生物群显著影响肝病的发展和进展. 通过便微生物种移植等干预措施调节肠道细菌,为治疗肝脏疾病提供了有希望的新策略.
科学领域:
- 胃肠病学和肝病学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 人们越来越认识到肠道微生物群在肝脏疾病的发病过程中起着至关重要的作用.
- 肠道失生症可能会损害肠道屏障的完整性,并破坏肠肝轴的免疫功能.
- 这种干扰有助于各种肝脏疾病的进展.
研究的目的:
- 审查目前关于肠道微生物群在肝脏疾病中的作用的研究.
- 突出分析肠道微生物组成和代谢物的诊断潜力.
- 探索针对肠道微生物群进行肝病管理的治疗策略.
主要方法:
- 关于肠道微生物群和肝脏疾病的最新研究的文献综述.
- 对便样本中的微生物组成和代谢物分析研究的分析.
- 综合有关肠道微生物群调节干预措施的发现.
主要成果:
- 肠道微生物群失生症与病毒性肝炎,酒精性脂肪肝病,与代谢功能障碍相关的脂肪性肝病,药物诱导的肝炎,肝硬化和肝细胞癌有关.
- 便微生物分析为肝脏疾病提供了辅助诊断信息.
- 包括便微生物群移植,益生菌,益生菌,细菌菌体和抗生素在内的干预措施显示出治疗潜力.
结论:
- 肠道微生物群是肝脏疾病的关键参与者.
- 微生物群分析提供了诊断见解.
- 准肠道微生物群为肝脏疾病提供了新的治疗途径.
相关概念视频
Microorganisms in Medicine and Therapeutics
375
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
375
Liver Regeneration
3.4K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.4K
Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
Inflammatory Bowel Disease IV: Pharmacological Management
204
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
204
Gastritis-II: Pathophysiology
601
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
601
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430


